The World Health Organisation (WHO) on Monday announced a temporary suspension of the trial of hydroxychloroquine for treatment of coronavirus patient.
The suspension of the trial, it said, was due to a higher mortality rate among patients receiving the drug.
The WHO announced this during its media briefing at its headquarters in Geneva, Switzerland.
Details later…..
YOU SHOULD NOT MISS THESE HEADLINES FROM NIGERIAN TRIBUNE
Buy and read digital replicas of your TRIBUNE titles by subscribing through E-VENDING
Pantami Used Armed Officers To Evict Our Staff, Abike Dabiri Alleges
The chairman, Nigerians in the Diaspora Commission (NIDCOM), Abike Dabiri-Erewa, has alleged that…
Source: Nigerian Tribune
